Showing results (191-200 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|November 3, 2022
A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordanceMartijn P D Haring, Arthur K E Elfrink, Christiaan A J Oudmaijer, et al.
Hepatology Communications|October 25, 2022
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver diseaseDivya Ayyala, Thomas Bottyan, Christine Tien, et al.
Hepatology Communications|October 25, 2022
Risk factors for cardiovascular disease among individuals with hepatic steatosisJulia Karády, Maros Ferencik, Thomas Mayrhofer, et al.
Hepatology Communications|October 26, 2022
Factors associated with cardiovascular events after simultaneous liver-kidney transplant from the US Multicenter Simultaneous Liver-Kidney Transplant ConsortiumJennifer Jo, Gonzalo Crespo, Dyanna Gregory, et al.
Hepatology Communications|October 10, 2022
Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acidDawei Ding, Guanya Guo, Yansheng Liu, et al.
Hepatology Communications|October 12, 2022
Evaluation of the definition of hyperdynamic circulation in patients with cirrhosis and ascitesCristina Ripoll, Luis Ibáñez-Samaniego, Beatrix Neumann, et al.
Hepatology Communications|October 5, 2022
Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in miceJie Jiang, Yuandi Ma, Yameng Liu, et al.
Hepatology Communications|October 6, 2022
Complement complex 1 subunit q-mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseasesAkiko Eguchi, Motoh Iwasa, Ryosuke Sugimoto, et al.
Hepatology Communications|September 7, 2022
The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in childrenAlexander Chaidez, Zhaoxing Pan, Shikha S Sundaram, et al.
Hepatology Communications|October 22, 2021
Liver Disease and Risk of Hepatocellular Carcinoma in Children With Mutations in TALDO1Tassos Grammatikopoulos, Nedim Hadzic, Pierre Foskett, et al.
Pageof 179